Su‐Hyun Kim

5.4k total citations
120 papers, 3.4k citations indexed

About

Su‐Hyun Kim is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Su‐Hyun Kim has authored 120 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Pathology and Forensic Medicine, 70 papers in Neurology and 32 papers in Rheumatology. Recurrent topics in Su‐Hyun Kim's work include Multiple Sclerosis Research Studies (84 papers), Peripheral Neuropathies and Disorders (57 papers) and Systemic Lupus Erythematosus Research (26 papers). Su‐Hyun Kim is often cited by papers focused on Multiple Sclerosis Research Studies (84 papers), Peripheral Neuropathies and Disorders (57 papers) and Systemic Lupus Erythematosus Research (26 papers). Su‐Hyun Kim collaborates with scholars based in South Korea, United States and United Kingdom. Su‐Hyun Kim's co-authors include Ho Jin Kim, Jae‐Won Hyun, Woojun Kim, So‐Young Huh, AeRan Joung, In Hye Jeong, Min Su Park, Sun Ju Lee, Jungnam Joo and Yeseul Kim and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Su‐Hyun Kim

113 papers receiving 3.3k citations

Peers

Su‐Hyun Kim
Jae‐Won Hyun South Korea
Maureen A. Mealy United States
Jeffrey Cohen United States
HP Hartung Germany
Su‐Hyun Kim
Citations per year, relative to Su‐Hyun Kim Su‐Hyun Kim (= 1×) peers Romain Marignier

Countries citing papers authored by Su‐Hyun Kim

Since Specialization
Citations

This map shows the geographic impact of Su‐Hyun Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su‐Hyun Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su‐Hyun Kim more than expected).

Fields of papers citing papers by Su‐Hyun Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su‐Hyun Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su‐Hyun Kim. The network helps show where Su‐Hyun Kim may publish in the future.

Co-authorship network of co-authors of Su‐Hyun Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Su‐Hyun Kim. A scholar is included among the top collaborators of Su‐Hyun Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su‐Hyun Kim. Su‐Hyun Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Ki Hoon, et al.. (2025). Discontinuation of Immunotherapy in Patients With Relapsing Myelitis Without AQP4/MOG Antibodies. Annals of Clinical and Translational Neurology. 12(8). 1689–1692. 1 indexed citations
2.
Kim, Yoo Hwan, et al.. (2024). The association between acute transverse myelitis and COVID‐19 vaccination in Korea: Self‐controlled case series study. European Journal of Neurology. 32(1). e70020–e70020.
3.
Kim, Su‐Hyun, Beung‐Chul Ahn, Dong-Eun Lee, et al.. (2024). Blood Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Promising Screening Biomarkers for Brain Metastases in Patients with Lung Cancer. International Journal of Molecular Sciences. 25(12). 6397–6397. 3 indexed citations
4.
Kim, Ki Hoon, Eun Young Park, Ho‐Shin Gwak, et al.. (2024). Disseminating Necrotizing Leukoencephalopathy Associated With Intra-CSF Methotrexate Chemotherapy. Neurology. 102(5). e209167–e209167. 3 indexed citations
5.
Kim, Ki Hoon, Su‐Hyun Kim, Na-Young Park, Jae‐Won Hyun, & Ho Jin Kim. (2022). Onset of various CNS inflammatory demyelination diseases following COVID-19 vaccinations. Multiple Sclerosis and Related Disorders. 68. 104141–104141. 8 indexed citations
6.
Kim, Ki Hoon, et al.. (2022). Seroprevalence of anti‐myelin oligodendrocyte glycoprotein antibodies in adults with myelitis. Annals of Clinical and Translational Neurology. 9(9). 1481–1486. 3 indexed citations
7.
Kim, Su‐Hyun, Ki Hoon Kim, Jae‐Won Hyun, et al.. (2022). Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers. Frontiers in Oncology. 12. 942960–942960. 15 indexed citations
8.
Huh, So‐Young, Su‐Hyun Kim, Ki Hoon Kim, et al.. (2022). Safety and Temporal Pattern of the Lymphocyte Count During Fingolimod Therapy in Patients With Multiple Sclerosis: Real-World Korean Experience. Journal of Clinical Neurology. 18(6). 663–663. 3 indexed citations
9.
Lee, Hye Lim, Su‐Hyun Kim, Jin Myoung Seok, et al.. (2022). Results of a Survey on Diagnostic Procedures and Treatment Choices for Neuromyelitis Optica Spectrum Disorder in Korea: Beyond the Context of Current Clinical Guidelines. Journal of Clinical Neurology. 18(2). 207–207. 5 indexed citations
10.
Hyun, Jae‐Won, Hye Lim Lee, Jae-Hong Park, et al.. (2021). Brighter spotty lesions on spinal MRI help differentiate AQP4 antibody-positive NMOSD from MOGAD. Multiple Sclerosis Journal. 28(6). 989–992. 10 indexed citations
11.
Hyun, Jae‐Won, et al.. (2021). Absence of attack-independent neuroaxonal injury in MOG antibody-associated disease: Longitudinal assessment of serum neurofilament light chain. Multiple Sclerosis Journal. 28(6). 993–999. 8 indexed citations
12.
Kim, Yeseul, Ha Eun Kim, Su‐Hyun Kim, et al.. (2021). Functional impairment of CD19 + CD24 hi CD38 hi B cells in neuromyelitis optica spectrum disorder is restored by B cell depletion therapy. Science Translational Medicine. 13(624). eabk2132–eabk2132. 10 indexed citations
13.
Kim, Ki Hoon, Su‐Hyun Kim, Na-Young Park, Jae‐Won Hyun, & Ho Jin Kim. (2021). Reappraisal of CSF-specific oligoclonal bands in Asia. Multiple Sclerosis Journal. 28(4). 665–668. 3 indexed citations
14.
Kim, Woojun, Eun Young Park, Jae‐Won Hyun, et al.. (2020). Validation of the Korean Version of the 12-Item Multiple Sclerosis Walking Scale and Application to Neuromyelitis Optica Spectrum Disorder. Journal of Clinical Neurology. 16(2). 270–270. 5 indexed citations
15.
Hyun, Jae‐Won, et al.. (2020). Incidence of interattack asymptomatic brain lesions in NMO spectrum disorder. Neurology. 95(23). e3124–e3128. 30 indexed citations
16.
Hyun, Jae‐Won, Na-Young Park, Su‐Hyun Kim, et al.. (2020). Comparison of Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis. Journal of Clinical Neurology. 16(1). 124–124. 17 indexed citations
17.
Choi, Sun Ah, Soo Yeon Kim, Hunmin Kim, et al.. (2020). Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Associated Disease in Korean Children. Journal of Clinical Neurology. 16(3). 461–461. 6 indexed citations
18.
Kim, Su‐Hyun, Yeseul Kim, Ji Yun Jung, et al.. (2019). High Seroprevalence and Index of Anti-John-Cunningham Virus Antibodies in Korean Patients with Multiple Sclerosis. Journal of Clinical Neurology. 15(4). 454–454. 5 indexed citations
19.
Hong, Yu Ah, Suk Young Kim, Su‐Hyun Kim, et al.. (2016). The Association of Visual Impairment With Clinical Outcomes in Hemodialysis Patients. Medicine. 95(19). e3591–e3591. 7 indexed citations
20.
Shin, Chaewon, et al.. (2009). Steroid Unresponsive Neuromyelitis Optica Improved With Plasmapheresis. Journal of the Korean Neurological Association. 27(4). 417–420. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026